Switch to:
More From Other Websites
Nasdaq stocks posting largest percentage increases Oct 21 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Oct 21 2014
4:02 pm Repros Therapeutics: results from long-term study of Androxal exhibit positive safety... Oct 21 2014
Results From Long-Term Study of Androxal(R) Exhibit Positive Safety Profile Oct 21 2014
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible... Oct 20 2014
INVESTOR ALERT: Investigation of Repros Therapeutics Inc. Announced by Glancy Binkow & Goldberg LLP Oct 20 2014
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics... Oct 20 2014
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000... Oct 17 2014
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Repros... Oct 17 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros... Oct 17 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Oct 17 2014
Repros Therapeutics shares drop on drug application setback Oct 17 2014
[$$] Repros Therapeutics Shares Drop Premarket Oct 17 2014
Upcoming FDA Meeting to be Type C Meeting Oct 16 2014
Upcoming FDA Meeting to be Type C Meeting Oct 16 2014
Can Repros Therapeutics Shares Still More Than Double? Sep 29 2014
Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% Sep 29 2014
US STOCKS-Biotech among biggest Nasdaq gainers Sep 26 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Sep 26 2014
FDA Schedules Type B Pre-NDA Meeting With Repros Sep 26 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK